CIK: 1181152 - Address: C/o Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150, Morrisville, NC 27560
4 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret112-1-869603
P%wins500505010050

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/7/11 16:39
12/5/11
FURXFuriex Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBondurant StuartNCDP.d5017.8713727D45-120338174-2-11-1122
5/12/11 10:37
5/11/11
FURXFuriex Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBondurant StuartNCDP.d5015.25135544D26-11-10-21-10-423-46
4/26/05 12:58
4/25/05
PPDIPharmaceutical Product Development IncNCHealthBiolabCommercial Physical & BiologiBondurant StuartNCDM.d73828.400264D
4/26/05 12:58
4/25/05
PPDIPharmaceutical Product Development IncNCHealthBiolabCommercial Physical & BiologiBondurant StuartNCDS.d-1,18745.640-26-884D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact